Philip Low Neurovigil Wikipedia, Biography
Dr. Philip Low is the Founder, Chairman, and CEO of NeuroVigil, Inc., a neurotechnology company renowned for developing the iBrain™, a portable brain activity monitor. He made his first scientific discovery at Harvard Medical School as a teenager. Dr. Low completed his PhD at the Salk Institute, where he authored a one-page thesis on dynamic brain activity mapping, leading to the creation of NeuroVigil.
Throughout his career, Dr. Low has received numerous accolades, including the Kavli Brain and Mind Innovative Research Award, the Draper Fisher Jurvetson Venture Challenge, and recognition as a Top Young Innovator under 35 by MIT Technology Review. He has held positions at the Stanford School of Medicine and the MIT Media Lab. His advisors have included notable figures such as the late Stephen Hawking, Nobel laureates Dr. Roger Guillemin and the late Dr. Sydney Brenner, and SpaceX and Tesla’s Elon Musk.
Early Life and Family
Born on August 16, 1979, in Vienna, Austria, Dr. Philip Low holds Canadian citizenship. He spent his formative years in Paris, France, where he developed a passion for mathematics and science. Details about his family background remain private, reflecting his preference to keep personal matters out of the public eye.
Education
Dr. Philip Low began his academic journey at the prestigious Institut Le Rosey in Switzerland, where he earned his French Scientific Baccalaureate with a focus on Mathematics. His time there established a strong foundation in analytical and scientific thinking, which would serve as a cornerstone for his future achievements.
He went on to study at The University of Chicago, where he obtained a Bachelor of Science degree in Pure Mathematics. During his time there, his interest in the biological sciences grew, leading him to pursue a summer research position at Harvard Medical School. At just a teenager, he made his first scientific discovery, demonstrating his early potential as a leading researcher.
Dr. Low later completed his Ph.D. in Computational Neurobiology at the University of California, San Diego, and The Salk Institute. His research focused on mapping dynamic brain activity, resulting in a groundbreaking one-page thesis that earned unanimous approval from his advisors. This pivotal work would ultimately inspire the development of NeuroVigil and the iBrain™.
Career
Dr. Philip Low’s career is defined by groundbreaking innovation, leadership in neuroscience, and impactful advisory roles across industries. His professional journey began during his time at The Salk Institute, where his research into dynamic brain activity mapping revolutionized the understanding of neurological functions. This work laid the foundation for his career as a pioneer in neurotechnology.
In 2007, Dr. Low founded NeuroVigil, Inc., a neurotechnology company focused on non-invasive brain activity monitoring. Under his leadership, NeuroVigil developed the iBrain™, a portable device capable of recording and analyzing brain activity through a single EEG channel. This technology has revolutionized how researchers and clinicians study neurological disorders such as sleep apnea, ALS, and autism. With its user-friendly design and cutting-edge algorithms, the iBrain™ has been utilized by leading pharmaceutical companies, research institutions, and even government agencies to advance neurological diagnostics and treatment.
Beyond NeuroVigil, Dr. Low has contributed to the academic and scientific communities through his work at institutions like Stanford School of Medicine and the MIT Media Lab. He has served as a mentor and collaborator in advancing computational neuroscience and neurotechnology. Furthermore, Dr. Low has played a key role in global advisory efforts, consulting for the Obama White House, NASA, the U.S. Armed Forces, and the United Nations. His work has spanned topics such as brain-machine interfaces, artificial intelligence, and national security.
Dr. Low’s career is also distinguished by his collaborations with world-renowned individuals, including the late Stephen Hawking, Nobel laureates Dr. Roger Guillemin and Dr. Sydney Brenner, and Elon Musk. He is known for bridging the gap between scientific theory and practical application, helping to translate innovative research into tools that benefit society. Through NeuroVigil and his advisory roles, Dr. Low has become a leading figure in the integration of technology and neuroscience, addressing critical challenges in healthcare and beyond.
Major Achievements
Dr. Low’s contributions to neuroscience and technology have been recognized through numerous awards:
- Kavli BrainwasheBrain and Mind Innovative Research Award
- Draper Fisher Jurvetson Venture Challenge Winner
- MIT TechnTechnologiesology Review’s Top Young Innovator Under 35
- Jacobs-Rady Pioneer Award for Global Innovation and Entrepreneurship
Additionally, he authored the Cambridge Declaration on Consciousness, the first formal document recognizing consciousness in non-human animals.
Net Worth
Specific details about Dr. Low’s net worth are not publicly disclosed. However, under his leadership, NeuroVigil has achieved significant valuations, reflecting the company’s impact and his success as an entrepreneur.
Personal Life
Dr. Low maintains a private personal life, and information about his marital status or partnerships is not publicly available. His focus remains on his professional endeavors and contributions to neuroscience.
Conclusion
Dr. Philip Low’s journey from a young scientist to a leading figure in neurotechnology exemplifies innovation and dedication. His work continues to influence the fields of neuroscience and technology, offering promising advancements for the future.
FAQs
What is Dr. Philip Low known for?
Dr. Low is known for founding NeuroVigil, Inc. and developing the iBrain™, a portable brain activity monitor.
Where was Dr. Philip Low born?
He was born in Vienna, Austria.
What is Dr. Low’s educational background?
He holds a Bachelor of Science in Pure Mathematics from The University of Chicago and a Ph.D. in Computational Neurobiology from the University of California, San Diego, and The Salk Institute.
What is the iBrain™?
The iBrain™ is a portable device developed by NeuroVigil for monitoring brain activity, with applications in sleep studies and neurological research.
Has Dr. Low received any awards?
Yes, he has received several awards, including the Kavli Brain and Mind Innovative Research Award and recognition as a Top Young Innovator Under 35 by MIT Technology Review.
What is the Cambridge Declaration on Consciousness?
Authored by Dr. Low, it is the first formal document recognizing consciousness in non-human animals.
Does Dr. Low have any advisory roles?
He has advised organizations such as the Obama White House, the U.S. Congress, NASA, and the U.S. Armed Forces on neurotechnology matters.
